Navigation Links
Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Date:6/25/2008

Alexandria, Va. The International Association for Dental Research (IADR) has selected Dr. Stuart Fischman, Professor of Oral Diagnostic Sciences (Emeritus) at the School of Dental Medicine, at the State University of New York, Buffalo, as the 2008 recipient of the Pharmacology/Therapeutics/Toxicology Research Award. The award will be presented at the IADR 86th General Session & Exhibition in Toronto, ON, Canada on July 2, 2008.

Dr. Fischman has made significant contributions to the evaluation of drugs used to prevent and treat the two most common diseases seen in dental practice - dental caries and periodontal diseases. The design and analysis of clinical trials of agents designed to prevent dental caries, calculus formation, and gingivitis complemented his activities in oral pathology and oral medicine. He designed and managed the studies, but also published many guidelines to aid colleagues in conducting such studies. His research studies, numbering more than 100, have evaluated a number of chemical agents for their ability to prevent calculus formation, reduce plaque accumulation, and prevent or reduce gingivitis. Several publications and presentations reviewed the various methodologies and indices, to provide "benchmarks" for colleagues. These publications continue to be widely cited in reviews and clinical trials.

Dr. Fischman has served the American Association for Dental Research (AADR) as a member of the Ethics Committee. This committee has made several recommendations to ensure that clinical trials are conducted in a professionally responsible manner. Dr. Fischman was a "founding member" of the IADR Pharmacology/Therapeutics/Toxicology Scientific Group. He served the Group as officer, rising through the ranks from "Member at Large" in 1979 to President in 1991. Although officially "retiring" in 1997, he remains very active in dental professional activities.

Supported by Wyeth Consumer Healthcare, the Pharmacology/Therapeutics/Toxicology Research Award is one of the 16 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by the IADR. The Award is made for outstanding and sustained peer-reviewed research that has contributed to our knowledge of the mechanisms, efficacy, or safety of drugs used in dentistry and consists of a cash prize and a plaque.


'/>"/>

Contact: Linda Hemphill
lhemphill@iadr.org
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Atchison receives Behavioral, Epidemiological and Health Services Research Award
2. Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter
3. Ukraines First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
4. Tasker Products Receives USDA Authorization to Begin Commercialization of its Post-Chill Spray Application
5. Advertising Hall of Famer Charles D. Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy
6. Findley Davies Receives IABC Vision Awards
7. NeoMend Receives FDA Panels Recommendation for Approval of ProGEL(TM) Surgical Sealant
8. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
9. DATATRAK International, Inc. Receives Notice From Nasdaq
10. AutoGenomics Receives a Key European Patent for HPV Detection
11. Rutgers scientist receives prestigious Young Investigator Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of McKinney ... Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. ... to Highway 121. , As the practice has grown, the need for more space ...
(Date:2/24/2017)... Diego, CA (PRWEB) , ... February 24, 2017 , ... ... its 2017 national conference convening academic faculty engaged in or interested in palliative care ... and Research,” will be held in North County San Diego on Sept. 28 ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that ... Chairman of the Management Committee when IFN was originally formed in 2002 where he ... and development of the business plan. He became the first paid employee of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... 2017 , ... On February 22, 2017 the U.S. Department ... withdraw previous guidance issued by the Obama Administration requiring schools to treat transgender ... by the Obama Administration came in response to a growing number of states ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... CHEYENNE, Wyoming , Feb. 24, 2017  Xynomic ... company, today announced that it has acquired exclusive ... a potentially best-in-class innovative HDAC inhibitor targeting hematological ... total of 14 Phase 1 and 2 clinical ... Asia have already been completed, ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... 2016" report to their offering. ... The latest research Autism Spectrum Disorder Drugs ... benchmarks in the global Autism Spectrum Disorder market. The research ... the key drugs marketed for Autism Spectrum Disorder and their clinical ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
Breaking Medicine Technology: